Ny Ag Announces 22 5 Mil Settlement With Abbott Labs
Last week, New York Attorney General Andrew Cuomo announced Abbott Laboratories and French drugmaker Fournier have agreed to pay $22.5 million to settle a case alleging the companies attempted to block the development of a generic alternative to their popular drug Tricor. Tricor was developed to help patients lower their “bad cholesterol” and raise “good cholesterol” to reduce the risk of heart attacks and strokes. The drugmakers will pay shares of the settlement to New York, 22 other states and the District of Columbia, according to a news release by the Attorney General’s office....